Table 3 Adverse events
Total adverse events | Eyes (n) | Total (%) | Patients (n) | Total (%) | Time of presentation |
|---|---|---|---|---|---|
Temporary haze | 16 | 10.25 | 13 | 11.6 | 1st month |
K max progression > 1 D | 13 | 8.33 | 8 | 5.1 | 24th–30th month |
Corneal transplants | 0 | 0 | 0 | 0 | 0 |
Overall progression | 13 | 8.33 | 8 | 5.1 | 24th–30th month |